» Articles » PMID: 34394095

Case Report: A Re-Positive Case of SARS-CoV-2 Associated With Glaucoma

Abstract

The current pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has already become a global threat to the human population. Infection with SARS-CoV-2 leads to a wide spectrum of clinical manifestations. Ocular abnormalities have been reported in association with COVID-19, but the nature of the impairments was not specified. Here, we report a case of a female patient diagnosed with glaucoma on re-hospitalization for ocular complications two months after being discharged from the hospital upon recovery from COVID-19. Meanwhile, the patient was found re-positive for SARS-CoV-2 in the upper respiratory tract. The infection was also diagnosed in the aqueous humor through immunostaining with antibodies against the N protein and S protein of SARS-CoV-2. Considering the eye is an immune-privileged site, we speculate that SARS-CoV-2 survived in the eye and resulted in the patient testing re-positive for SARS-CoV-2.

Citing Articles

Ocular neuroinflammatory response secondary to SARS-CoV-2 infection-a review.

Zhao Y, Tang Y, Wang Q, Li J Front Immunol. 2025; 16:1515768.

PMID: 39967658 PMC: 11832381. DOI: 10.3389/fimmu.2025.1515768.


SARS-CoV-2 infects cells lining the blood-retinal barrier and induces a hyperinflammatory immune response in the retina via systemic exposure.

Monu M, Ahmad F, Olson R, Balendiran V, Singh P PLoS Pathog. 2024; 20(4):e1012156.

PMID: 38598560 PMC: 11034659. DOI: 10.1371/journal.ppat.1012156.


Manifestations of coronavirus infection disease-19 in anterior eye segment: An up-to-date review.

Marzoog B Oman J Ophthalmol. 2024; 17(1):4-10.

PMID: 38524336 PMC: 10957037. DOI: 10.4103/ojo.ojo_237_22.


The Outbreak of Acute Primary Angle-Closure Cases During the COVID-19 Omicron Variant Pandemic at a Tertiary Eye Center in Shanghai.

Huang H, Dai Y, Sun X, Fang Y Clin Ophthalmol. 2024; 17:4009-4019.

PMID: 38162694 PMC: 10757803. DOI: 10.2147/OPTH.S440740.


New-onset Glaucoma Following Moderna COVID-19 Vaccination.

Su Y, Yeh S, Chen M J Curr Glaucoma Pract. 2023; 17(2):106-109.

PMID: 37485459 PMC: 10357024. DOI: 10.5005/jp-journals-10078-1408.


References
1.
Tillett R, Sevinsky J, Hartley P, Kerwin H, Crawford N, Gorzalski A . Genomic evidence for reinfection with SARS-CoV-2: a case study. Lancet Infect Dis. 2020; 21(1):52-58. PMC: 7550103. DOI: 10.1016/S1473-3099(20)30764-7. View

2.
Long Q, Tang X, Shi Q, Li Q, Deng H, Yuan J . Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020; 26(8):1200-1204. DOI: 10.1038/s41591-020-0965-6. View

3.
Azzolini C, Donati S, Premi E, Baj A, Siracusa C, Genoni A . SARS-CoV-2 on Ocular Surfaces in a Cohort of Patients With COVID-19 From the Lombardy Region, Italy. JAMA Ophthalmol. 2021; 139(9):956-963. PMC: 7934077. DOI: 10.1001/jamaophthalmol.2020.5464. View

4.
DArdes D, Boccatonda A, Rossi I, Pontolillo M, Cocco G, Schiavone C . Long-term Positivity to SARS-CoV-2: A Clinical Case of COVID-19 with Persistent Evidence of Infection. Eur J Case Rep Intern Med. 2020; 7(6):001707. PMC: 7279900. DOI: 10.12890/2020_001707. View

5.
Chin M, Hooper L, Hooks J, Detrick B . Identification of α-fodrin as an autoantigen in experimental coronavirus retinopathy (ECOR). J Neuroimmunol. 2014; 272(1-2):42-50. PMC: 7112846. DOI: 10.1016/j.jneuroim.2014.05.002. View